Viewing Study NCT00566995

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:13 PM
Ignite Modification Date: 2026-02-11 @ 7:35 AM
Study NCT ID: NCT00566995
Status: COMPLETED
Last Update Posted: 2018-10-30
First Post: 2007-12-01
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase II Study of Vandetanib in Individuals With Kidney Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cancer View
None Von Hippel Lindau View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Kidney Tumors View
None Clear Cell Renal Cancer View
None VEGFR Inhibitor View
None EGFR Inhibitor View
None VHL View
None Von Hippel Lindau View
None Kidney Tumor View